Pds biotech announces preclinical publication in peer reviewed viruses journal showing superior cd4 t cell induction by infectimune™

Infectimune™ (r-dotap) nanoparticles significantly enhance cytokine-inducing, cd4 t cell responses compared to leading commercial adjuvants being used in approved vaccines infectimune™ (r-dotap) nanoparticles significantly enhance cytokine-inducing, cd4 t cell responses compared to leading commercial adjuvants being used in approved vaccines
PDSB Ratings Summary
PDSB Quant Ranking